COMMUNIQUÉS West-GlobeNewswire

ORYZON to Reshape Its Board of Directors at the Upcoming Shareholders’ Meeting
27/01/2025
Aimed at enhancing U.S. outreach, investor relations, corporate dialogue, and business development (BD) capabilities MADRID and CAMBRIDGE, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: [...]
PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor
27/01/2025
PetVivo Board Appoints Eldred as Executive Director to Lead Company Product Commercialization and Operations MINNEAPOLIS, MN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading [...]
BioCardia Announces Late Breaking Clinical Trial Presentation on CardiAMP Heart Failure Trial at the American College of Cardiology 2025 Scientific Sessions
27/01/2025
SUNNYVALE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA] today announced that the results of its double-blind randomized placebo-controlled CardiAMP HF Phase 3 study have been accepted for [...]
Nine Levers Employers Can Use to Improve Brain Health and Workplace Performance
27/01/2025
New unified model developed by UsAgainstAlzheimer's, the Davos Alzheimer's Collaborative and the McKinsey Health Institute provides roadmap for employers to promote employee brain health for better business outcomes [...]
Intuitive Announces $45 Million Donation to the Intuitive Foundation to Promote Health and Advance Education
27/01/2025
Latest donation brings total contribution to more than $170 million SUNNYVALE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of [...]
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
27/01/2025
- High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of Alpha DaRT ® - - Ad-hoc analyses of pancreatic cancer population subgroups [...]
FDA Authorizes Myocene Device for Muscle Fatigue Monitoring and Informed Training Decisions
27/01/2025
LIÈGE, Belgium, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Myocene, the Belgian sportstech company specializing in innovative muscle fatigue assessment for top-level athletes announced today that the US Food and Drug [...]
KFSHRC Heart Centre: A Leader in Advanced Cardiac Treatments
27/01/2025
Revolutionizing care from minimally invasive surgery to comprehensive outpatient services RIYADH, Saudi Arabia, Jan. 27, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has [...]
Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT
27/01/2025
Study is the first randomized, controlled trial examining a vaccine’s effectiveness in controlling CMV in recipients of HSCT from vaccinated donors Encouraging pilot study results demonstrated the benefit of vaccinating [...]
Novo Nordisk A/S - share repurchase programme
27/01/2025
Bagsværd, Denmark, 27 January 2025 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April [...]
Umoja Biopharma Announces Appointment of Dr. Luke Walker as Chief Medical Officer
27/01/2025
SEATTLE, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, today announced the [...]
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
27/01/2025
BERKELEY, Calif. and MAINZ, Germany, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of [...]
Bicara Therapeutics Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa in Advanced Squamous Cancer of the Anal Canal at the 2025 ASCO Gastrointestinal Cancers Symposium
27/01/2025
BOSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
Life Biosciences Appoints Dr. Michael Ringel as Chief Operating Officer
27/01/2025
BOSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today announced the [...]
Aspargo Labs Appoints Harold D. Tamayo as Chief Financial Officer
27/01/2025
Experienced financial leader joins as the company prepares for its public market entry NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc., (“Aspargo Labs” or the “Company”), a specialty pharmacy and MedTech [...]
Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter
27/01/2025
ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received European CE Mark [...]
iCAD Pre-Announces Estimated Q4 2024 Revenue
27/01/2025
iCAD to Participate in the BTIG at Snowbird: 12 th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference NASHUA, N.H., Jan. 27, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the [...]
Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
27/01/2025
JERUSALEM, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced that it will [...]
Acuitive Technologies, Inc. Appoints Dr. Wayne Berberian as Chief Medical Officer
27/01/2025
Acuitive Technologies announces the appointment of Dr. Wayne Berberian as Chief Medical Officer. In this role, Dr. Berberian will drive the company’s strategy behind new product development of first-in-class [...]

Pages